Roger Owen Selected Research

indacaterol

5/2012	Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
10/2011	Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
7/2011	Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study.
6/2011	Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
5/2011	Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
2/2011	Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study.
1/2011	Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data.
10/2010	Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
9/2010	Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone.
7/2010	Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Owen Research Topics

Disease

15	Chronic Obstructive Pulmonary Disease (COPD) 05/2012 - 07/2008
8	Multiple Myeloma 01/2022 - 09/2013
4	Neoplasms (Cancer) 01/2022 - 10/2017
4	Breast Neoplasms (Breast Cancer) 12/2012 - 05/2002
3	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 05/2006
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2020 - 05/2006
3	Asthma (Bronchial Asthma) 12/2008 - 12/2007
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2009
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 04/2013
2	Schnitzler Syndrome 01/2020 - 01/2018
2	Dyspnea (Shortness of Breath) 05/2012 - 05/2011
1	Frailty 01/2022
1	Atrial Fibrillation 01/2022
1	Diarrhea 01/2022
1	Fever (Fevers) 01/2022
1	Infections 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Hemolytic Anemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Skin Diseases (Skin Disease) 01/2020
1	Vasculitis (Vasculitides) 01/2019
1	Disease Progression 03/2018
1	Monoclonal Gammopathy of Undetermined Significance 12/2017
1	Residual Neoplasm 01/2016
1	Trisomy (Trisomies) 04/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2010
1	Cough 03/2010
1	Lymphadenopathy 01/2009
1	Amyloidosis 01/2009
1	Cytopenia 01/2009
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2009
1	Cryoglobulinemia 01/2009
1	Acute Promyelocytic Leukemia 01/2004
1	Mydriasis 03/2002

Drug/Important Bio-Agent (IBA)

17	indacaterolIBA 05/2012 - 12/2007
10	Bronchodilator Agents (Bronchodilators)IBA 05/2012 - 07/2008
5	Immunoglobulin M (IgM)IBA 01/2022 - 05/2006
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2016
3	Bortezomib (Velcade)FDA Link 01/2022 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2004
3	Formoterol Fumarate (Oxis)FDA Link 05/2012 - 02/2009
3	Salmeterol Xinafoate (Serevent)FDA Link 05/2011 - 09/2010
2	Rituximab (Mabthera)FDA Link 01/2022 - 07/2010
2	ixazomibIBA 01/2022 - 03/2018
2	ibrutinibIBA 01/2022 - 01/2022
2	Proteasome InhibitorsIBA 01/2021 - 03/2018
2	carfilzomibIBA 01/2021 - 01/2016
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2018
2	Thalidomide (Thalomid)FDA Link 03/2018 - 09/2013
2	Pharmaceutical PreparationsIBA 10/2017 - 03/2002
2	Albuterol (Salbutamol)FDA LinkGeneric 07/2011 - 09/2010
2	Tiotropium Bromide (Spiriva)FDA Link 10/2010 - 07/2010
1	zanubrutinibIBA 01/2022
1	fludarabineIBA 01/2022
1	Everolimus FDA Link 01/2022
1	Bendamustine Hydrochloride FDA Link 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	CryoglobulinsIBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	ParaproteinsIBA 01/2020
1	CytokinesIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 12/2017
1	Immunoglobulin A (IgA)IBA 12/2017
1	Immunomodulating AgentsIBA 10/2017
1	Biological ProductsIBA 04/2013
1	Fluticasone (Cutivate)FDA LinkGeneric 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2008
1	Beclomethasone (Beclometasone)FDA Link 12/2007
1	Codon (Codons)IBA 04/2005
1	Superoxide DismutaseIBA 05/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2009
4	Radiotherapy 12/2012 - 05/2002
3	Dry Powder Inhalers 02/2009 - 12/2007
1	Drug Tapering 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Plasma Exchange 01/2022
1	Plasmapheresis 01/2022
1	Transplantation 01/2022
1	Stem Cell Transplantation 01/2022
1	Premedication 01/2021
1	Salvage Therapy 01/2009
1	Autologous Transplantation 01/2009